Etiopathogenesis of Graves' disease

Neuroendocrinology Letters

Volumn 24, Issue 3-4, 2003, Pages 161-166

  Karasek, Michal ^a   Lewinski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Autoimmune diseases; Dermopathy; Graves' disease; Hyperthyroidism; Ophtalmopathy

Indexed keywords

THYROID HORMONE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; DISEASE PREDISPOSITION; EYE DISEASE; GENETIC SUSCEPTIBILITY; GOITER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LYMPHOCYTIC INFILTRATION; PATHOGENESIS; RECEPTOR BINDING; REVIEW; RISK FACTOR; SKIN DISEASE; SKIN INFILTRATE; THEORY; THYROID CELL; THYROID DISEASE; THYROID HORMONE RELEASE; THYROID HORMONE SYNTHESIS;

EID: 0041785432     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Nauman J, Nauman A. Choroba Gravesa-Basedowa; etiopatogeneza, klinika, leczenie [(Graves' Basedow disease; etiopathogenesis, clinic, and treatment.) (In Polish with English abstract.)]. Endokrynol Pol - Polish J Endocrinol 1995; 46(suppl 1/1):3-8.
2. Baj Z, Ferenc T, Lewinski A. (1998) Immunopatologia choroby Gravesa-Basedowa [(Immunopathology of Graves' Basedow disease.) (In Polish with English abstract.)]. Post Hig Med Dosw 1998; 51:531-46.
3. Weetman AP. (2000) Graves' disease. N Eng J Med 2000; 343:1236-48.
4. Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy. Endocrinol Metab Clin North Am 2000; 29:297-319.
5. McIver B, Morris JC. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am 1998; 77:73-89.
6. Weetman AP. New aspects of thyroid immunity. Horm Res 1997; 48(suppl 4):51-4.
7. Nauman J. Wyniki badan programu MZ-XVII prowadzonych w skali kraju; podsumowanie i wnioski [(Results of studies performed within MZ-XVII programme; most important observations and conclusions of country-wide studies.) (In Polish with English abstract.)]. Endokrynol Pol - Polish J Endocrinol 1991; 42:359-67.
8. Berglund J, Ericsson UB, Hallengren B. (1996) Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974. J Intern Med 1996; 239: 57-62.
9. Okamura K, Nakashima T, Ueda K, Inoue K, Omae T, Fujishima M. Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences. Int J Epidemiol 1987; 16:545-9.
10. Tomer Y, Davies TF. The genetic susceptibility to Graves' disease. Bailliere's Clin Endocrinol Metab 1997; 11:431-50.
11. Brix TH, Kyvik KO, Hedegus L. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid 1998; 8:727-34.
12. Gough SC. The genetics of Graves' disease. Endocrinol Metab Clin North Am 2000; 29:255-66.
13. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85:311-8.
14. Luppi P, Rosiello MR, Faas S, Trucco M. Genetic background and environment contribute synergistically to the onset of autoimmune diseases. J Mol Med 1995; 73:381-93.
15. Steinman L. Escape from "horror autotoxicus" pathogenesis and treatment of autoimmune disease. Cell 1995; 80:7-10.
16. Anderson G, Anderson L, Larhmmar D, Rask L, Siguardardottir S. Simplifying genetic locus assignment of HLA-DRB genes. Immunol Today 1994; 15:58-62.
17. Volpe R, Row VV. (1985) Role for an antigen-specific defect in suppressor T lymphocyte fubction in autoimmune thyroid diseases. In: Walfish P, Wall JR, Volpe R, editors. Autoimmunity in thyroid diseases. New York: Academic Press; 1985. p. 79-93.
18. Chistyakov DA, Savost'anov KV, Turakulav RI, Nosikov VV. (2000) Genetic determinants of Graves disease. Mol Genet Metab 2000; 71:66-9.
19. Boehm BO, Kuhnl P, Manfras BJ, Chen M, Lee JC, Holzberger G et al. HLA-DRB3 gene alleles in Caucasian patients with Graves disease. Clin Invest 1992; 70:956-60.
20. Badenhoop K, Walfish PG, Rau H, Fisher S, Nicolay A, Bogner U et al. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 1995; 80:2112-2117.
21. Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 1998; 83:3394-7.
22. Blakemore AIF, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80:111-5.
23. Yanagawa T, Hidaka Y, Guimaracs V, Soliman M, Degroot IJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995; 80:41-5.
24. Watson PF, French A, Pickerill AP, McIntosh RS, Weetman AP. Lack of association between a point mutation in the coding region of the TSH receptor gene and Graves' disease. J Clin Endocrinol Metab 1995; 80:1032-5.
25. Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams RC et al. An investigation of thyroid stimulating antibody activity between different IgG subclasses. J Clin Invest 1990; 86:723-7.
26. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TE. Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1). J Clin Endocrinol Metab 1998; 83:4321-7.
27. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TE. A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 1998; 63:1749-56.
28. Barbesino G, Tomer Y, Concepcion ES, Davies TE, Greenberg DA. (1998) Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. J Clin Endocrinol Metab 1998; 83:3290-5.
29. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D et al. Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am J Hum Gene 2000; 66:1710-1714.
30. Tomer Y, Davies TF. Infection, thyroid disease and autoimmunity. Endocrine Rev 1993; 14:107-19.
31. Wenzel BE, Franke TF, Heufelder AE, Hessemann J. Autoimmune thyroid diseases and entheropathogenic Yersinia enterocolitica. Autoimmunity 1990; 7:295-303.
32. Furmaniak J, Smith BR. Immunity to the thyroid-stimulating hormone receptor. Immunopathol 1993; 14:309-21.
33. Bahn RS, Dutton CHN, Heufelder AE, Sarkar G. A genomic pint mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophtalmopathy. J Clin Endocrinol Metab 1994; 78:256-60.
34. Koop P, van Sande J, Parma J, Duprez L, Gerber H, Joss E et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995; 332:150-4.
35. Tokorarbet L, Ropars A, Raby C, Charreire J. (1995) Phenothiazine induces de novo MHC class II antigen expression on thyroid epithelial cells. J Immunol 1995; 154:3593-602.
36. Delamarre FGA, Drexhage HA. (1996) Leukocyte migration into autoimmune diseased endocrine tissues. Eur J Endocrinol 1996; 34:9-11.
37. Drexhage HA. Autoimmunity and thyroid growth. Where do we stand? Eur J Endocrinol 1996; 135:39-45.
38. Phillips DIW, Cooper C, Fall C, Prentice L, Osmond C, Barker DJP et al. Fetal growth and autoimmune thyroid disease. Q J Med 1993; 86:247-53.
39. Misrahi M, Loosefelt H, Atger M, Sar S, Goiochou-Mantel A, Milgrom E. Cloning sequencing and expression of human TSH receptor. Biochem Biophys Res Commun 1990; 166:394-9.
40. Paschke R, Ludgate M. The thyrotropin receptor and thyroid disease. New Engl J Med 1997; 337:1675-81.
41. Rapoport B, Chazenbalk GD, Juarne JC, McLachlan SM. The thyrotropin receptor: interaction with TSH and autoantibodies. Endocr Rev 1998; 19:673-716.
42. Chazelbalk GD, Wang Y, Guo J, Hutchison JS, Segal D, Jaume JC et al. A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentrations in human autoantibodies. J Clin Endocrinol Metab 1999; 84:702-10.
43. Kosugi S, Ban T, Akamizu T, Valente W, Kohn LD. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema who have blocking TSHR antibodies. J Clin Endocrinol Metab 1993; 77:19-24.
44. Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TE. (1997) Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease, J Clin Endocrinol Metab 1997; 82:3361-6.
45. Aust G, Lehmann I, Laue S, Scherbaum WA. Activated and interferon-gamma producing thyroid-derived T cells are detected in Graves' disease, thyroid autonomy as well as in non-toxic multinodular goiter. Eur J Endocrinol 1996; 135:60-8.
46. Kabel PJ, Voorbij HA, de Haan-Meulman M, Pals ST, Drexhage HA. High endothelial venules present in lymphoid cell accumulation in thyroids affected by autoimmune disease: a study in men and BB rats of functional activity and development. J Clin Endocrinol Metab 1989; 68:744-51.
47. Aust G, Scherbaum WA. Expression of cytokines in the thyroid: thyrocytes as potential cytokine producers. Exp Clin Endocrinol Diabetes 1996; 104(suppl 4):64-7.
48. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2:1115-9.
49. Heufelder AE, Smith TJ, Gorman CA, Bahn RS. Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy. J Clin Endocrinol Metab 1991; 73:307-13.
50. Marelli-Berg FM, Weetman A, Frasca L, Deacock SJ, Imami N, Lombardi G et al. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD451 T cells. J Immunol 1997; 59:5853-5861.
51. Di Cerbo A, Di Paola R, Bonati M, Zingrillo M, De Filippis V, Corda D. Subgroups of Graves' patients identified on the basis of the biochemical activities of their immunoglobulins. J Clin Endocrinol Metab 1995; 80:2785-90.
52. Di Paola R, Menzaghi C, De Filippis V, Corda D, Di Cerbo A. Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves' disease. J Clin Endocrinol Metab 1997; 82:670-3.
53. Lewinski A, Pawlikowski M, Cardinali DP. Thyroid growth-stimulating and growth-inhibiting factors. Biol Signals 1993; 2:313-51.
54. Lewinski A, Klencki M. (1995) Obecny stan wiedzy na temat czynnikow regulujacych procesy wzrostowe gruczolu tarczowego [(Factors involved in the regulation of thyroid growth processes - current status of research) (In Polish with English abstract.)]. Endokr Pol - Pol J Endocrinol 1995; 46(suppl 1/1):9-23.
55. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993; 329:1468-75.
56. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocrine Rev 1993; 14:747-93.
57. Perros P, Kendall-Taylor P. Thyroid associated ophthalmopathy: pathogenesis and clinical management. Baillieres Clin Endocrinol Metab 1995; 9:115-35.
58. Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinolol (Oxford) 1995; 42:45-50.
59. Wall JR, Salvi M, Bernard NF. Thyroid associated ophthalmopathy: a model for the association of organ-specific autoimmune disorders. Immunology Today 1991; 12:150-3.
60. Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 1991; 338:25-8.
61. Bednarczuk T, Hiromatsu Y, Wall JR, Nauman J. T cell mediated immunity in thyroid-associated ophthalmopathy. Progress in Thyroid Associated Ophthalmopathy, Satelite Symposium 12th International Thyroid Congress, Kyoto, Abstract Book, 2000. p. 33-40.
62. 131I and thyroid-associated ophthalmopathy. Eur J Endocrinol 2000; 155-60.
63. Heufelder AE, Dutton CM, Sarkar G, Donnonvan KA, Bahn RS. Detection of THS receptor DNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 1993; 3:297-330.
64. Bahn R, Dutton C, Natt N, Jobs W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves' orbital adipose tissue/ connective tissue: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 1998; 83:998-1002.
65. Kasper M, Archibald C, De Bellis AM, Li AW, Yamada M, Chang HC et al. Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy. Progress in Thyroid Associated Ophthalmopathy, Satelite Symposium 12th International Thyroid Congress, Kyoto, Abstract Book, 2000. p. 13-8.
66. Kiljanski J, Nebes V, Wall JR. The ocular muscle is the target of the immune system in endocrine ophthalmopathy. Intl Arch Allerg Immunol 1995; 106:206-212.
67. Wall JR. Extra thyroidal manifestations of Graves' disease. J Clin Endocrinol Metab 1995; 80:3427-9.
68. Heufelder AE. Pathogenesis of Graves' ophthalmopathy: recent controversies and progress. Eur J Endocrinol 1995; 132:532-41.
69. Hiromatsu Y. Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Progress in Thyroid Associated Ophthalmopathy, Satelite Symposium 12th International Thyroid Congress, Kyoto, Abstract Book, 2000. p. 41-5.
70. Somach SC, Helm TN, Lawor KB, Bergfeld WF, Bass J. Pretibial mucin: histologic patterns and clinical correlation. Arch Dermatol 1993; 129:1152-6.
71. Peacey SR, Flemming L, Messenger A, Weetman AP. Is Graves' dermopathy a generalized disorder? Thyroid 1996; 6:41-5.
72. Wortsman J, Dietrich J, Traycoff RB, Stone S. Preradial myxedema in theroid disease. Arch Dermatol 1981; 117:635-8.
73. Smith TJ, Bahn RS, Gorman CA. (1989) Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10:366-91.